Table of Content

1 Human Coagulation Factor Ⅷ Market Overview
1.1 Human Coagulation Factor Ⅷ Product Scope
1.2 Human Coagulation Factor Ⅷ Segment by Type
1.2.1 Global Human Coagulation Factor Ⅷ Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Factor VIII
1.2.3 Human Factor VIII
1.3 Human Coagulation Factor Ⅷ Segment by Application
1.3.1 Global Human Coagulation Factor Ⅷ Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hemophilia A
1.3.3 Relvent Bleeding Diseases
1.4 Human Coagulation Factor Ⅷ Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Coagulation Factor Ⅷ Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Coagulation Factor Ⅷ Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Coagulation Factor Ⅷ Price Trends (2016-2027)

2 Human Coagulation Factor Ⅷ Estimates and Forecasts by Region
2.1 Global Human Coagulation Factor Ⅷ Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Coagulation Factor Ⅷ Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2016-2021)
2.2.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Region (2016-2021)
2.3 Global Human Coagulation Factor Ⅷ Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Coagulation Factor Ⅷ Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Coagulation Factor Ⅷ Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Coagulation Factor Ⅷ Estimates and Projections (2016-2027)
2.4.2 Europe Human Coagulation Factor Ⅷ Estimates and Projections (2016-2027)
2.4.3 China Human Coagulation Factor Ⅷ Estimates and Projections (2016-2027)
2.4.4 Japan Human Coagulation Factor Ⅷ Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Coagulation Factor Ⅷ Estimates and Projections (2016-2027)
2.4.6 India Human Coagulation Factor Ⅷ Estimates and Projections (2016-2027)

3 Global Human Coagulation Factor Ⅷ Competition Landscape by Players
3.1 Global Top Human Coagulation Factor Ⅷ Players by Sales (2016-2021)
3.2 Global Top Human Coagulation Factor Ⅷ Players by Revenue (2016-2021)
3.3 Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2020)
3.4 Global Human Coagulation Factor Ⅷ Average Price by Company (2016-2021)
3.5 Manufacturers Human Coagulation Factor Ⅷ Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Coagulation Factor Ⅷ Market Size by Type
4.1 Global Human Coagulation Factor Ⅷ Historic Market Review by Type (2016-2021)
4.1.1 Global Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
4.1.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Coagulation Factor Ⅷ Price by Type (2016-2021)
4.2 Global Human Coagulation Factor Ⅷ Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Coagulation Factor Ⅷ Sales Forecast by Type (2022-2027)
4.2.2 Global Human Coagulation Factor Ⅷ Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Coagulation Factor Ⅷ Price Forecast by Type (2022-2027)

5 Global Human Coagulation Factor Ⅷ Market Size by Application
5.1 Global Human Coagulation Factor Ⅷ Historic Market Review by Application (2016-2021)
5.1.1 Global Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
5.1.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Coagulation Factor Ⅷ Price by Application (2016-2021)
5.2 Global Human Coagulation Factor Ⅷ Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Coagulation Factor Ⅷ Sales Forecast by Application (2022-2027)
5.2.2 Global Human Coagulation Factor Ⅷ Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Coagulation Factor Ⅷ Price Forecast by Application (2022-2027)

6 North America Human Coagulation Factor Ⅷ Market Facts & Figures
6.1 North America Human Coagulation Factor Ⅷ Sales by Company
6.1.1 North America Human Coagulation Factor Ⅷ Sales by Company (2016-2021)
6.1.2 North America Human Coagulation Factor Ⅷ Revenue by Company (2016-2021)
6.2 North America Human Coagulation Factor Ⅷ Sales Breakdown by Type
6.2.1 North America Human Coagulation Factor Ⅷ Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Coagulation Factor Ⅷ Sales Breakdown by Type (2022-2027)
6.3 North America Human Coagulation Factor Ⅷ Sales Breakdown by Application
6.3.1 North America Human Coagulation Factor Ⅷ Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Coagulation Factor Ⅷ Sales Breakdown by Application (2022-2027)

7 Europe Human Coagulation Factor Ⅷ Market Facts & Figures
7.1 Europe Human Coagulation Factor Ⅷ Sales by Company
7.1.1 Europe Human Coagulation Factor Ⅷ Sales by Company (2016-2021)
7.1.2 Europe Human Coagulation Factor Ⅷ Revenue by Company (2016-2021)
7.2 Europe Human Coagulation Factor Ⅷ Sales Breakdown by Type
7.2.1 Europe Human Coagulation Factor Ⅷ Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Coagulation Factor Ⅷ Sales Breakdown by Type (2022-2027)
7.3 Europe Human Coagulation Factor Ⅷ Sales Breakdown by Application
7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Human Coagulation Factor Ⅷ Market Facts & Figures
8.1 China Human Coagulation Factor Ⅷ Sales by Company
8.1.1 China Human Coagulation Factor Ⅷ Sales by Company (2016-2021)
8.1.2 China Human Coagulation Factor Ⅷ Revenue by Company (2016-2021)
8.2 China Human Coagulation Factor Ⅷ Sales Breakdown by Type
8.2.1 China Human Coagulation Factor Ⅷ Sales Breakdown by Type (2016-2021)
8.2.2 China Human Coagulation Factor Ⅷ Sales Breakdown by Type (2022-2027)
8.3 China Human Coagulation Factor Ⅷ Sales Breakdown by Application
8.3.1 China 156 Sales Breakdown by Application (2016-2021)
8.3.2 China 156 Sales Breakdown by Application (2022-2027)

9 Japan Human Coagulation Factor Ⅷ Market Facts & Figures
9.1 Japan Human Coagulation Factor Ⅷ Sales by Company
9.1.1 Japan Human Coagulation Factor Ⅷ Sales by Company (2016-2021)
9.1.2 Japan Human Coagulation Factor Ⅷ Revenue by Company (2016-2021)
9.2 Japan Human Coagulation Factor Ⅷ Sales Breakdown by Type
9.2.1 Japan Human Coagulation Factor Ⅷ Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Coagulation Factor Ⅷ Sales Breakdown by Type (2022-2027)
9.3 Japan Human Coagulation Factor Ⅷ Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Coagulation Factor Ⅷ Market Facts & Figures
10.1 Southeast Asia Human Coagulation Factor Ⅷ Sales by Company
10.1.1 Southeast Asia Human Coagulation Factor Ⅷ Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Coagulation Factor Ⅷ Revenue by Company (2016-2021)
10.2 Southeast Asia Human Coagulation Factor Ⅷ Sales Breakdown by Type
10.2.1 Southeast Asia Human Coagulation Factor Ⅷ Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Coagulation Factor Ⅷ Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Coagulation Factor Ⅷ Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Human Coagulation Factor Ⅷ Market Facts & Figures
11.1 India Human Coagulation Factor Ⅷ Sales by Company
11.1.1 India Human Coagulation Factor Ⅷ Sales by Company (2016-2021)
11.1.2 India Human Coagulation Factor Ⅷ Revenue by Company (2016-2021)
11.2 India Human Coagulation Factor Ⅷ Sales Breakdown by Type
11.2.1 India Human Coagulation Factor Ⅷ Sales Breakdown by Type (2016-2021)
11.2.2 India Human Coagulation Factor Ⅷ Sales Breakdown by Type (2022-2027)
11.3 India Human Coagulation Factor Ⅷ Sales Breakdown by Application
11.3.1 India Human Coagulation Factor Ⅷ Sales Breakdown by Application (2016-2021)
11.3.2 India Human Coagulation Factor Ⅷ Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Coagulation Factor Ⅷ Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Human Coagulation Factor Ⅷ Products Offered
12.1.5 Bayer Recent Development
12.2 CSL Behring
12.2.1 CSL Behring Corporation Information
12.2.2 CSL Behring Business Overview
12.2.3 CSL Behring Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Behring Human Coagulation Factor Ⅷ Products Offered
12.2.5 CSL Behring Recent Development
12.3 Baxter
12.3.1 Baxter Corporation Information
12.3.2 Baxter Business Overview
12.3.3 Baxter Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter Human Coagulation Factor Ⅷ Products Offered
12.3.5 Baxter Recent Development
12.4 Grifols
12.4.1 Grifols Corporation Information
12.4.2 Grifols Business Overview
12.4.3 Grifols Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Grifols Human Coagulation Factor Ⅷ Products Offered
12.4.5 Grifols Recent Development
12.5 Octapharma
12.5.1 Octapharma Corporation Information
12.5.2 Octapharma Business Overview
12.5.3 Octapharma Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Octapharma Human Coagulation Factor Ⅷ Products Offered
12.5.5 Octapharma Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Human Coagulation Factor Ⅷ Products Offered
12.6.5 Pfizer Recent Development
12.7 Taibang Bio
12.7.1 Taibang Bio Corporation Information
12.7.2 Taibang Bio Business Overview
12.7.3 Taibang Bio Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Taibang Bio Human Coagulation Factor Ⅷ Products Offered
12.7.5 Taibang Bio Recent Development
12.8 Shanghai Laishi
12.8.1 Shanghai Laishi Corporation Information
12.8.2 Shanghai Laishi Business Overview
12.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Shanghai Laishi Human Coagulation Factor Ⅷ Products Offered
12.8.5 Shanghai Laishi Recent Development
12.9 Hualan Bio
12.9.1 Hualan Bio Corporation Information
12.9.2 Hualan Bio Business Overview
12.9.3 Hualan Bio Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hualan Bio Human Coagulation Factor Ⅷ Products Offered
12.9.5 Hualan Bio Recent Development
12.10 Guangdong Shuanglin
12.10.1 Guangdong Shuanglin Corporation Information
12.10.2 Guangdong Shuanglin Business Overview
12.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Guangdong Shuanglin Human Coagulation Factor Ⅷ Products Offered
12.10.5 Guangdong Shuanglin Recent Development
12.11 GreenCross
12.11.1 GreenCross Corporation Information
12.11.2 GreenCross Business Overview
12.11.3 GreenCross Human Coagulation Factor Ⅷ Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GreenCross Human Coagulation Factor Ⅷ Products Offered
12.11.5 GreenCross Recent Development

13 Human Coagulation Factor Ⅷ Manufacturing Cost Analysis
13.1 Human Coagulation Factor Ⅷ Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Coagulation Factor Ⅷ
13.4 Human Coagulation Factor Ⅷ Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Coagulation Factor Ⅷ Distributors List
14.3 Human Coagulation Factor Ⅷ Customers

15 Market Dynamics
15.1 Human Coagulation Factor Ⅷ Market Trends
15.2 Human Coagulation Factor Ⅷ Drivers
15.3 Human Coagulation Factor Ⅷ Market Challenges
15.4 Human Coagulation Factor Ⅷ Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Coagulation Factor Ⅷ Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Coagulation Factor Ⅷ Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Coagulation Factor Ⅷ Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Coagulation Factor Ⅷ Sales (K Units) by Region (2016-2021)
Table 5. Global Human Coagulation Factor Ⅷ Sales Market Share by Region (2016-2021)
Table 6. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Coagulation Factor Ⅷ Revenue Share by Region (2016-2021)
Table 8. Global Human Coagulation Factor Ⅷ Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Human Coagulation Factor Ⅷ Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Coagulation Factor Ⅷ Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Coagulation Factor Ⅷ Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Human Coagulation Factor Ⅷ Sales Share by Company (2016-2021)
Table 14. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Coagulation Factor Ⅷ Revenue Share by Company (2016-2021)
Table 16. Global Human Coagulation Factor Ⅷ by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor Ⅷ as of 2020)
Table 17. Global Human Coagulation Factor Ⅷ Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Human Coagulation Factor Ⅷ Manufacturing Sites and Area Served
Table 19. Manufacturers Human Coagulation Factor Ⅷ Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Coagulation Factor Ⅷ Sales (K Units) by Type (2016-2021)
Table 22. Global Human Coagulation Factor Ⅷ Sales Share by Type (2016-2021)
Table 23. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Coagulation Factor Ⅷ Price (US$/Unit) by Type (2016-2021)
Table 25. Global Human Coagulation Factor Ⅷ Sales Share by Type (2022-2027)
Table 26. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Coagulation Factor Ⅷ Revenue Share by Type (2022-2027)
Table 28. Global Human Coagulation Factor Ⅷ Price (US$/Unit) by Type (2022-2027)
Table 29. Global Human Coagulation Factor Ⅷ Sales (K Units) by Application (2016-2021)
Table 30. Global Human Coagulation Factor Ⅷ Sales Share by Application (2016-2021)
Table 31. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Coagulation Factor Ⅷ Price (US$/Unit) by Application (2016-2021)
Table 33. Global Human Coagulation Factor Ⅷ Sales (K Units) by Application (2022-2027)
Table 34. Global Human Coagulation Factor Ⅷ Sales Share by Application (2022-2027)
Table 35. Global Human Coagulation Factor Ⅷ Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Coagulation Factor Ⅷ Revenue Share by Application (2022-2027)
Table 37. Global Human Coagulation Factor Ⅷ Price (US$/Unit) by Application (2022-2027)
Table 38. North America Human Coagulation Factor Ⅷ Sales (K Units) by Company (2016-2021)
Table 39. North America Human Coagulation Factor Ⅷ Sales Market Share by Company (2016-2021)
Table 40. North America Human Coagulation Factor Ⅷ Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Coagulation Factor Ⅷ Revenue Market Share by Company (2016-2021)
Table 42. North America Human Coagulation Factor Ⅷ Sales by Type (2016-2021) & (K Units)
Table 43. North America Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
Table 44. North America Human Coagulation Factor Ⅷ Sales by Type (2022-2027) & (K Units)
Table 45. North America Human Coagulation Factor Ⅷ Sales Market Share by Type (2022-2027)
Table 46. North America Human Coagulation Factor Ⅷ Sales by Application (2016-2021) & (K Units)
Table 47. North America Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
Table 48. North America Human Coagulation Factor Ⅷ Sales by Application (2022-2027) & (K Units)
Table 49. North America Human Coagulation Factor Ⅷ Sales Market Share by Application (2022-2027)
Table 50. Europe Human Coagulation Factor Ⅷ Sales (K Units) by Company (2016-2021)
Table 51. Europe Human Coagulation Factor Ⅷ Sales Market Share by Company (2016-2021)
Table 52. Europe Human Coagulation Factor Ⅷ Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Coagulation Factor Ⅷ Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Coagulation Factor Ⅷ Sales by Type (2016-2021) & (K Units)
Table 55. Europe Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
Table 56. Europe Human Coagulation Factor Ⅷ Sales by Type (2022-2027) & (K Units)
Table 57. Europe Human Coagulation Factor Ⅷ Sales Market Share by Type (2022-2027)
Table 58. Europe Human Coagulation Factor Ⅷ Sales by Application (2016-2021) & (K Units)
Table 59. Europe Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
Table 60. Europe Human Coagulation Factor Ⅷ Sales by Application (2022-2027) & (K Units)
Table 61. Europe Human Coagulation Factor Ⅷ Sales Market Share by Application (2022-2027)
Table 62. China Human Coagulation Factor Ⅷ Sales (K Units) by Company (2016-2021)
Table 63. China Human Coagulation Factor Ⅷ Sales Market Share by Company (2016-2021)
Table 64. China Human Coagulation Factor Ⅷ Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Coagulation Factor Ⅷ Revenue Market Share by Company (2016-2021)
Table 66. China Human Coagulation Factor Ⅷ Sales by Type (2016-2021) & (K Units)
Table 67. China Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
Table 68. China Human Coagulation Factor Ⅷ Sales by Type (2022-2027) & (K Units)
Table 69. China Human Coagulation Factor Ⅷ Sales Market Share by Type (2022-2027)
Table 70. China Human Coagulation Factor Ⅷ Sales by Application (2016-2021) & (K Units)
Table 71. China Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
Table 72. China Human Coagulation Factor Ⅷ Sales by Application (2022-2027) & (K Units)
Table 73. China Human Coagulation Factor Ⅷ Sales Market Share by Application (2022-2027)
Table 74. Japan Human Coagulation Factor Ⅷ Sales (K Units) by Company (2016-2021)
Table 75. Japan Human Coagulation Factor Ⅷ Sales Market Share by Company (2016-2021)
Table 76. Japan Human Coagulation Factor Ⅷ Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Coagulation Factor Ⅷ Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Coagulation Factor Ⅷ Sales by Type (2016-2021) & (K Units)
Table 79. Japan Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
Table 80. Japan Human Coagulation Factor Ⅷ Sales by Type (2022-2027) & (K Units)
Table 81. Japan Human Coagulation Factor Ⅷ Sales Market Share by Type (2022-2027)
Table 82. Japan Human Coagulation Factor Ⅷ Sales by Application (2016-2021) & (K Units)
Table 83. Japan Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
Table 84. Japan Human Coagulation Factor Ⅷ Sales by Application (2022-2027) & (K Units)
Table 85. Japan Human Coagulation Factor Ⅷ Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Coagulation Factor Ⅷ Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Coagulation Factor Ⅷ Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Coagulation Factor Ⅷ Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Coagulation Factor Ⅷ Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Coagulation Factor Ⅷ Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Coagulation Factor Ⅷ Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Coagulation Factor Ⅷ Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Application (2022-2027)
Table 98. India Human Coagulation Factor Ⅷ Sales (K Units) by Company (2016-2021)
Table 99. India Human Coagulation Factor Ⅷ Sales Market Share by Company (2016-2021)
Table 100. India Human Coagulation Factor Ⅷ Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Coagulation Factor Ⅷ Revenue Market Share by Company (2016-2021)
Table 102. India Human Coagulation Factor Ⅷ Sales by Type (2016-2021) & (K Units)
Table 103. India Human Coagulation Factor Ⅷ Sales Market Share by Type (2016-2021)
Table 104. India Human Coagulation Factor Ⅷ Sales by Type (2022-2027) & (K Units)
Table 105. India Human Coagulation Factor Ⅷ Sales Market Share by Type (2022-2027)
Table 106. India Human Coagulation Factor Ⅷ Sales by Application (2016-2021) & (K Units)
Table 107. India Human Coagulation Factor Ⅷ Sales Market Share by Application (2016-2021)
Table 108. India Human Coagulation Factor Ⅷ Sales by Application (2022-2027) & (K Units)
Table 109. India Human Coagulation Factor Ⅷ Sales Market Share by Application (2022-2027)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Bayer Human Coagulation Factor Ⅷ Product
Table 114. Bayer Recent Development
Table 115. CSL Behring Corporation Information
Table 116. CSL Behring Description and Business Overview
Table 117. CSL Behring Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. CSL Behring Human Coagulation Factor Ⅷ Product
Table 119. CSL Behring Recent Development
Table 120. Baxter Corporation Information
Table 121. Baxter Description and Business Overview
Table 122. Baxter Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Baxter Human Coagulation Factor Ⅷ Product
Table 124. Baxter Recent Development
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Business Overview
Table 127. Grifols Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Grifols Human Coagulation Factor Ⅷ Product
Table 129. Grifols Recent Development
Table 130. Octapharma Corporation Information
Table 131. Octapharma Description and Business Overview
Table 132. Octapharma Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Octapharma Human Coagulation Factor Ⅷ Product
Table 134. Octapharma Recent Development
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Pfizer Human Coagulation Factor Ⅷ Product
Table 139. Pfizer Recent Development
Table 140. Taibang Bio Corporation Information
Table 141. Taibang Bio Description and Business Overview
Table 142. Taibang Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Taibang Bio Human Coagulation Factor Ⅷ Product
Table 144. Taibang Bio Recent Development
Table 145. Shanghai Laishi Corporation Information
Table 146. Shanghai Laishi Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Shanghai Laishi Description and Business Overview
Table 148. Shanghai Laishi Human Coagulation Factor Ⅷ Product
Table 149. Shanghai Laishi Recent Development
Table 150. Hualan Bio Corporation Information
Table 151. Hualan Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Hualan Bio Description and Business Overview
Table 153. Hualan Bio Human Coagulation Factor Ⅷ Product
Table 154. Hualan Bio Recent Development
Table 155. Guangdong Shuanglin Corporation Information
Table 156. Guangdong Shuanglin Description and Business Overview
Table 157. Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product
Table 159. Guangdong Shuanglin Recent Development
Table 160. GreenCross Corporation Information
Table 161. GreenCross Description and Business Overview
Table 162. GreenCross Human Coagulation Factor Ⅷ Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. GreenCross Human Coagulation Factor Ⅷ Product
Table 164. GreenCross Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Human Coagulation Factor Ⅷ Distributors List
Table 168. Human Coagulation Factor Ⅷ Customers List
Table 169. Human Coagulation Factor Ⅷ Market Trends
Table 170. Human Coagulation Factor Ⅷ Market Drivers
Table 171. Human Coagulation Factor Ⅷ Market Challenges
Table 172. Human Coagulation Factor Ⅷ Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor Ⅷ Product Picture
Figure 2. Global Human Coagulation Factor Ⅷ Sales Market Share by Type in 2021 & 2027
Figure 3. Recombinant Factor VIII Product Picture
Figure 4. Human Factor VIII Product Picture
Figure 5. Global Human Coagulation Factor Ⅷ Sales Market Share by Application in 2021 & 2027
Figure 6. Hemophilia A Examples
Figure 7. Relvent Bleeding Diseases Examples
Figure 8. Global Human Coagulation Factor Ⅷ Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Human Coagulation Factor Ⅷ Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Human Coagulation Factor Ⅷ Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Human Coagulation Factor Ⅷ Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 12. Global Human Coagulation Factor Ⅷ Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Human Coagulation Factor Ⅷ Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Human Coagulation Factor Ⅷ Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Human Coagulation Factor Ⅷ Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Human Coagulation Factor Ⅷ Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Human Coagulation Factor Ⅷ Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Human Coagulation Factor Ⅷ Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Human Coagulation Factor Ⅷ Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Human Coagulation Factor Ⅷ Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Human Coagulation Factor Ⅷ Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Human Coagulation Factor Ⅷ Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Human Coagulation Factor Ⅷ Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Human Coagulation Factor Ⅷ Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Human Coagulation Factor Ⅷ Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Human Coagulation Factor Ⅷ Players Market Share by Revenue in Human Coagulation Factor Ⅷ: 2016 & 2020
Figure 27. Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Human Coagulation Factor Ⅷ Revenue Share by Type (2016-2021)
Figure 29. Global Human Coagulation Factor Ⅷ Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Human Coagulation Factor Ⅷ Revenue Share by Application (2016-2021)
Figure 31. Global Human Coagulation Factor Ⅷ Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 33. North America Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 34. Europe Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 35. Europe Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 36. China Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 37. China Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 38. Japan Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 39. Japan Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 40. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 41. Southeast Asia Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 42. India Human Coagulation Factor Ⅷ Sales Market Share by Type in 2020
Figure 43. India Human Coagulation Factor Ⅷ Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Human Coagulation Factor Ⅷ
Figure 46. Manufacturing Process Analysis of Human Coagulation Factor Ⅷ
Figure 47. Human Coagulation Factor Ⅷ Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed